These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 10328107)
1. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429 [TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961 [TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Wang ZG; Rivi R; Delva L; König A; Scheinberg DA; Gambacorti-Passerini C; Gabrilove JL; Warrell RP; Pandolfi PP Blood; 1998 Sep; 92(5):1497-504. PubMed ID: 9716575 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells. Li X; Ding X; Adrian TE Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). Michel L; Dupuy A; Jean-Louis F; Sors A; Poupon J; Viguier M; Musette P; Dubertret L; Degos L; Dombret H; Bachelez H J Invest Dermatol; 2003 Oct; 121(4):881-93. PubMed ID: 14632209 [TBL] [Abstract][Full Text] [Related]
11. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis]. Shen Y; Chen G; Cai X Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):259-61. PubMed ID: 11776809 [TBL] [Abstract][Full Text] [Related]
12. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686 [TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells]. Zhou Y; Huang X; Cai X Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):181-3. PubMed ID: 11783079 [TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Baj G; Arnulfo A; Deaglio S; Mallone R; Vigone A; De Cesaris MG; Surico N; Malavasi F; Ferrero E Breast Cancer Res Treat; 2002 May; 73(1):61-73. PubMed ID: 12083632 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line. Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131 [TBL] [Abstract][Full Text] [Related]
16. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines. Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054 [TBL] [Abstract][Full Text] [Related]
17. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400 [TBL] [Abstract][Full Text] [Related]
18. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
19. [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells]. Cai X; Chen G; Jia P Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):452-5. PubMed ID: 11715442 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice. Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]